A study suggests that a reduced dose of enfortumab vedotin may lower toxicity in older patients with urothelial carcinoma, ...

Bladder and Urothelial Cancer Trials to Watch at ESMO 2026 / bladder cancer, cancer, cancer care, Cancer research, cancer ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that 21 abstracts from its oncology portfolio will be presented at the European Society for Medical ...

New research shows that BH3 mimetic drugs targeting antiapoptotic Bcl-2 family proteins can sensitize bladder cancer cells ...

In Part 1, I wrote about how cancers of the urinary tract present with the sign of "painless, yet intermittent" hematuria, ...

Daiichi Sankyo (4568.TS) and AstraZeneca (AZN) have entered into a clinical trial collaboration agreement with Summit Therapeutics (SMMT) to evaluate Datroway (datopotamab deruxtecan) in combination ...

A three-point scoring system that requires nothing more than a blood count, a brief assessment of a patient’s physical ...

ImmunityBio (IBRX) stock jumped 12% after a fund highlighted Anktiva's market potential, new global partnerships, and an ongoing bladder cancer trial.

Starting tomorrow, National Health Insurance will be applied, virtually for the first time, to a combination therapy that ...

South Korea expands insurance to cover three cancer drugs and first combo Coverage widens from October for Retsevmo, Vyloy, ...

Korea will cover the Padcev-Keytruda combination for urothelial cancer from Oct. 1, the first reimbursement of new drugs from ...

ICI unmet need through differentiated, biomarker-guided therapies, strategic pipeline prioritization, competitive benchmarking, and market access planning across the 7MM.Dublin, Sept. 30, 2026 (GLOBE ...